Published by Josh White on 11th May 2023
(Sharecast News) - Cell engineering specialist MaxCyte saw its shares slide on Thursday, after it updated its revenue guidance for the year on the back of its first quarter performance.
URL: http://www.digitallook.com/dl/news/story/33496571/...